Sensus Healthcare(DE:5TX)
€2.78+0.24 (+6.92%)
DE:5TX
Sensus Healthcare financials statements
€2.78
At close:+0.24 (+6.92%)
Sensus Healthcare (5TX) Ratios
2 Followers
Sensus Healthcare Ratios
DE:5TX's free cash flow for Q2 2026 was $-3.13M. For the 2026 fiscal year, DE:5TX's free cash flow was increased by $3.00K and operating cash flow was $-3.13M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.72 | 9.64 | 11.76 | 6.92 | 5.24 |
| Quick Ratio | 6.63 | 7.93 | 8.94 | 6.46 | 4.94 |
| Cash Ratio | 4.68 | 3.75 | 5.50 | 3.32 | 2.43 |
| Solvency Ratio | -1.44 | 1.12 | 0.19 | 2.86 | 0.76 |
| Operating Cash Flow Ratio | 0.11 | -0.14 | -0.51 | -0.18 | -0.05 |
| Short-Term Operating Cash Flow Coverage | 2.02 | 0.00 | 0.00 | 0.00 | -5.61 |
| Net Current Asset Value | $ 40.95M | $ 50.40M | $ 44.66M | $ 44.58M | $ 25.02M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.10 | 1.11 | 1.10 | 1.18 | 1.24 |
| Debt Service Coverage Ratio | -27.07 | 0.00 | 0.00 | 5797.00 | 91.04 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 7415.50 | 4120.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 0.04 | 0.05 | 0.06 | 0.01 |
| Net Debt to EBITDA | 2.38 | -2.27 | -283.10 | -1.60 | -3.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.18% | 58.44% | 57.61% | 66.53% | 62.82% |
| EBIT Margin | -35.02% | 21.58% | -1.57% | 33.30% | 15.24% |
| EBITDA Margin | -32.74% | 22.61% | 0.32% | 34.45% | 17.51% |
| Operating Profit Margin | -37.50% | 19.35% | -1.57% | 33.30% | 15.24% |
| Pretax Profit Margin | -35.02% | 21.58% | 2.67% | 62.85% | 15.23% |
| Net Profit Margin | -28.09% | 15.90% | 1.99% | 54.44% | 15.23% |
| Continuous Operations Profit Margin | -28.09% | 15.90% | 1.99% | 54.44% | 15.23% |
| Net Income Per EBT | 80.21% | 73.68% | 74.39% | 86.62% | 100.00% |
| EBT Per EBIT | 93.37% | 111.52% | -170.68% | 188.73% | 99.98% |
| Return on Assets (ROA) | -14.55% | 10.69% | 0.90% | 42.73% | 12.78% |
| Return on Equity (ROE) | -16.05% | 11.91% | 0.99% | 50.44% | 15.83% |
| Return on Capital Employed (ROCE) | -21.33% | 14.37% | -0.77% | 30.24% | 15.68% |
| Return on Invested Capital (ROIC) | -17.02% | 10.55% | -0.57% | 26.10% | 15.55% |
| Return on Tangible Assets | -14.55% | 10.69% | 0.90% | 42.77% | 12.83% |
| Earnings Yield | -11.88% | 5.89% | 1.26% | 19.83% | 3.46% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.55 | 2.12 | 2.29 | 2.57 | 2.23 |
| Payables Turnover | 4.67 | 3.61 | 3.70 | 2.70 | 2.48 |
| Inventory Turnover | 1.07 | 1.72 | 0.87 | 4.26 | 5.72 |
| Fixed Asset Turnover | 11.32 | 16.22 | 19.71 | 35.94 | 34.94 |
| Asset Turnover | 0.52 | 0.67 | 0.45 | 0.78 | 0.84 |
| Working Capital Turnover Ratio | 0.60 | 0.87 | 0.54 | 1.26 | 1.19 |
| Cash Conversion Cycle | 342.50 | 283.30 | 479.15 | 92.32 | 80.26 |
| Days of Sales Outstanding | 80.23 | 172.26 | 159.21 | 141.79 | 163.72 |
| Days of Inventory Outstanding | 340.41 | 212.10 | 418.49 | 85.74 | 63.86 |
| Days of Payables Outstanding | 78.14 | 101.06 | 98.54 | 135.21 | 147.32 |
| Operating Cycle | 420.64 | 384.36 | 577.69 | 227.53 | 227.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.03 | -0.05 | -0.13 | -0.09 | -0.02 |
| Free Cash Flow Per Share | 0.02 | -0.07 | -0.15 | -0.10 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | 2.69 | -3.01 | -9.37 | -8.88 | -2.23 |
| Capital Expenditure Coverage Ratio | 2.69 | -3.01 | -9.37 | -8.88 | -2.23 |
| Operating Cash Flow Coverage Ratio | 0.78 | -1.38 | -2.74 | -1.38 | -1.27 |
| Operating Cash Flow to Sales Ratio | 0.02 | -0.02 | -0.09 | -0.03 | -0.01 |
| Free Cash Flow Yield | 0.51% | -0.98% | -6.19% | -1.28% | -0.35% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.47 | 16.88 | 79.12 | 5.04 | 28.88 |
| Price-to-Sales (P/S) Ratio | 2.36 | 2.70 | 1.57 | 2.75 | 4.40 |
| Price-to-Book (P/B) Ratio | 1.35 | 2.02 | 0.79 | 2.54 | 4.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 195.73 | -101.97 | -16.16 | -77.84 | -287.34 |
| Price-to-Operating Cash Flow Ratio | 123.07 | -135.84 | -17.89 | -86.61 | -415.94 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | 0.01 | -0.81 | 0.01 | -0.18 |
| Enterprise Value Multiple | -4.84 | 9.67 | 202.62 | 6.37 | 22.11 |
| Enterprise Value | 43.58M | 91.43M | 16.01M | 97.79M | 104.66M |
| EV to EBITDA | -4.84 | 9.67 | 202.62 | 6.37 | 22.11 |
| EV to Sales | 1.59 | 2.19 | 0.66 | 2.20 | 3.87 |
| EV to Free Cash Flow | 131.26 | -82.59 | -6.74 | -62.25 | -252.81 |
| EV to Operating Cash Flow | 82.53 | -110.02 | -7.46 | -69.26 | -365.96 |
| Tangible Book Value Per Share | 2.95 | 3.42 | 3.00 | 2.91 | 1.57 |
| Shareholders’ Equity Per Share | 2.95 | 3.42 | 3.00 | 2.92 | 1.58 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.26 | 0.26 | 0.13 | 0.00 |
| Revenue Per Share | 1.68 | 2.56 | 1.50 | 2.70 | 1.64 |
| Net Income Per Share | -0.47 | 0.41 | 0.03 | 1.47 | 0.25 |
| Tax Burden | 0.80 | 0.74 | 0.74 | 0.87 | 1.00 |
| Interest Burden | 1.00 | 1.00 | -1.71 | 1.89 | 1.00 |
| Research & Development to Revenue | 0.28 | 0.10 | 0.15 | 0.08 | 0.13 |
| SG&A to Revenue | 0.52 | 0.29 | 0.21 | 0.11 | 0.17 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 |
| Income Quality | -0.07 | -0.13 | -4.42 | -0.06 | -0.07 |
Currency in USD
